Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Comparative Analysis of Specific Expression of Melanoma-Associated Antibodies

Continue reading
06 2 月

Week 30 of “Mai Mai” Pathology Reading Notes | Immunohistochemical Markers for Diagnosing Other Lymphohematopoietic System Tumors

Continue reading
06 2 月

The Past, Present, and Future of HER-2

Continue reading
06 2 月

We Arrived as Promised on the Same Day!

Continue reading
06 2 月

Fifteen Years of Splendor: Advancing Together with the Chinese Journal of Pathology

Continue reading
06 2 月

SOX-10: A Novel Indicator for Differential Diagnosis and Prognosis in Triple-Negative Breast Cancer

Continue reading
06 2 月

2011 National Symposium on Immunohistochemistry Successfully Concluded

Continue reading
06 2 月

Application and Pitfalls of Immunohistochemical Antibodies in Diagnosing Urogenital Diseases (Part 1)

Continue reading
06 2 月

Second Round Meeting Notice for Cross-Strait Precision Medicine-Molecular Pathology Diagnosis Training Course

Continue reading
06 2 月

Common Molecular Marker for Glioma: IDH

Continue reading
  • «
  • ‹
  • 44
  • 45
  • 46
  • 47
  • 48
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar